Table 1.
Diagnostic evaluation in a patient with MARS mutations
Disorders investigated | Investigations performed (normal unless otherwise indicated) |
---|---|
General investigations |
• Serology for Hepatitis B, C, EBV, CMV; PCR for HIV |
• Alpha-1-antitrypsin and Pi type | |
• Sweat test | |
• Chromosomal microarray analysis: Paternally inherited duplication of 3p14.2 (616 kb) including C3orf67 | |
• Immunoglobulin levels, neutrophil oxidative burst activity, lymphocyte subpopulations | |
Disorders of intermediary metabolism |
• Glucose, creatine kinase |
• Serum amino acids including homocysteine | |
• Urine organic acids (including succinylacetone)(during liver failure, tyrosine metabolites but not succinylacetone observed) | |
• Serum ceruloplasmin, serum and urine copper | |
• Serum iron profile: Iron 65 μg/dl (nl 50-120); iron binding capacity, unsaturated <20 μg/dl (nl 100-400), iron binding capacity total 40 μg/dl (nl 250-450), transferrin saturation 162% (nl 10-45); ferritin 1053 ng/ml (nl 50-200) | |
• Galactosemia metabolic panel (GALT, Gal-1 PO4 levels and DNA testing) | |
• Acylcarnitine profile | |
Disorders of energy metabolism |
• Glucose profiling; lactate 3.4 mmol/L (nl 0.5-1.5), pyruvate 0.32 mmol/L (nl 0.03-0.08); CSF lactate 3.5, CSF pyruvate 0.19 |
• Muscle biopsy: histology, histochemistry, electron microscopy, respiratory chain enzyme analysis, muscle mtDNA content, mtDNA analysis for deletions and rearrangements, mtDNA sequencing | |
• Muscle biopsy: excess of type IIC muscle fibers, immunostaining for succinate dehydrogenase and cytochrome c oxidase normal, normal mitochondrial appearance by electron microscopy | |
• DGUOK, MPV17, and POLG1 sequencing | |
• Ornithine decarbamylase gene sequencing | |
• Liver biopsy: cholestasis, steatosis, bridging necrosis, minimal fibrosis, hemosiderin laden macrophages in the portal tracts, and normal appearing mitochondria and electron microscopy (Figure 1B-C), liver respiratory chain analysis, liver mtDNA content | |
• Urine sugar and polyol and plasma sterol analyses | |
• Initial aminoaciduria resolved | |
• BCS1L sequencing for GRACILE (growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death) syndrome | |
• Ophthalmology and cardiology assessments | |
• MRI and CT scan of brain | |
Disorders of complex molecules |
• Isoelectric focusing consistent with liver failure |
• White cell lysosomal enzyme screen | |
• Wolman disease (lysosomal acid lipase deficiency) | |
• Lysinuric protein intolerance (SLC7A7) | |
• Urine mucopolysaccharides and oligosaccharides | |
• Niemann-Pick types A and B (sphingomyelinase deficiency), and C (fibroblasts), GM1 gangliosidosis, and Gaucher disease | |
• Bone marrow aspirate: RBC maturation arrest (precursors but not mature RBCs present); normal 5’nucleotidase | |
• Plasma very long chain fatty acid analysis | |
• Plasma and urine bile acid analysis, plasma cholesterol |